Yorktown Management & Research CO Inc Biogen Inc. Transaction History

Yorktown Management & Research CO Inc

  • $93.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 06, 2020
SELL
$264.77 - $305.71 $238,292 - $275,139
-900 Closed
0 $0
Q1 2020

Apr 29, 2020
SELL
$268.85 - $341.04 $80,655 - $102,312
-300 Reduced 25.0%
900 $285,000
Q3 2019

Nov 01, 2019
BUY
$217.44 - $243.88 $260,928 - $292,656
1,200 New
1,200 $279,000

Others Institutions Holding BIIB

# of Institutions
1,015
Shares Held
126M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Yorktown Management & Research CO Inc Portfolio

Follow Yorktown Management & Research CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Yorktown Management & Research CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email